Table 1.
ESAs classification per strength (IU/mcg) and price between originator &biosimilar products in 2012
|
Originators | |||
|---|---|---|---|
| Brand | Strength | Active substance | Average hospital price/syringe (€)* |
| |
150 MCG |
|
192.27 |
| ARANESP |
300 MCG |
Darbepoetin α |
385.11 |
| 500 MCG |
|
635.49 |
|
| |
10.000 IU |
|
60.79 |
| NEO RECORMON |
20.000 IU |
Epoetin β |
149.68 |
| 30.000 IU |
|
190.16 |
|
| 60.000 IU |
|
342.25 |
|
| 10.000 IU |
|
53.9 |
|
| EPREX |
20.000 IU |
Epoetin α |
122.79 |
| 30.000 IU |
|
196.55 |
|
| 40.000 IU |
|
212.42 |
|
|
Biosimilars | |||
|
Brand |
Strength |
Active substance |
Average hospital price/syringe (€)* |
| ABSEAMED |
10.000 IU |
|
50.26 |
| 20.000 IU |
Epoetin α |
101.91 |
|
| 30.000 IU |
|
152.87 |
|
| 40.000 IU |
|
203.83 |
|
| 10.000 IU |
|
47.41 |
|
| BINOCRIT |
20.000 IU |
Epoetin α |
94.37 |
| 30.000 IU |
|
141.55 |
|
| 40.000 IU |
|
188.73 |
|
| 10.000 IU |
Epoetin ζ |
54.51 |
|
| RETACRIT | 40.000 IU | 255.54 | |
*Hospital Prices 2012.